Form 8-K - Current report:
SEC Accession No. 0001193125-24-211080
Filing Date
2024-08-30
Accepted
2024-08-30 16:10:54
Documents
15
Period of Report
2024-08-30
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d889003d8k.htm   iXBRL 8-K 26423
2 EX-99.1 d889003dex991.htm EX-99.1 17136
6 GRAPHIC g889003g0830215155781.jpg GRAPHIC 3177
  Complete submission text file 0001193125-24-211080.txt   177098

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA iobt-20240830.xsd EX-101.SCH 2857
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE iobt-20240830_lab.xml EX-101.LAB 17911
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE iobt-20240830_pre.xml EX-101.PRE 11239
17 EXTRACTED XBRL INSTANCE DOCUMENT d889003d8k_htm.xml XML 3616
Mailing Address OLE MAALOES VEH 3 COPENHAGEN G7 2200
Business Address OLE MAALOES VEH 3 COPENHAGEN G7 2200 4570702980
IO Biotech, Inc. (Filer) CIK: 0001865494 (see all company filings)

EIN.: 870909276 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41008 | Film No.: 241270143
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)